126 related articles for article (PubMed ID: 34532530)
1. Protocol for
Ota K; Harada T
Bio Protoc; 2018 Nov; 8(21):e3067. PubMed ID: 34532530
[TBL] [Abstract][Full Text] [Related]
2. Visualization and quantitation of epidermal growth factor receptor homodimerization and activation with a proximity ligation assay.
Ota K; Harada T; Otsubo K; Fujii A; Tsuchiya Y; Tanaka K; Okamoto I; Nakanishi Y
Oncotarget; 2017 Sep; 8(42):72127-72132. PubMed ID: 29069773
[TBL] [Abstract][Full Text] [Related]
3. Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non-small cell lung cancer patients treated with osimertinib.
Liu R; Ota K; Iwama E; Yoneshima Y; Tanaka K; Inoue H; Tagawa T; Oda Y; Mori M; Nakanishi Y; Okamoto I
Lung Cancer; 2021 Aug; 158():156-161. PubMed ID: 34059353
[TBL] [Abstract][Full Text] [Related]
4. SH2-PLA: a sensitive in-solution approach for quantification of modular domain binding by proximity ligation and real-time PCR.
Thompson CM; Bloom LR; Ogiue-Ikeda M; Machida K
BMC Biotechnol; 2015 Jun; 15():60. PubMed ID: 26112401
[TBL] [Abstract][Full Text] [Related]
5. In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy.
Gajadhar AS; Bogdanovic E; Muñoz DM; Guha A
Mol Cancer Res; 2012 Mar; 10(3):428-40. PubMed ID: 22232519
[TBL] [Abstract][Full Text] [Related]
6. Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays.
Smith MA; Hall R; Fisher K; Haake SM; Khalil F; Schabath MB; Vuaroqueaux V; Fiebig HH; Altiok S; Chen YA; Haura EB
Sci Signal; 2015 Jan; 8(359):ra4. PubMed ID: 25587191
[TBL] [Abstract][Full Text] [Related]
7. Proximity ligation assay combined with flow cytometry is a powerful tool for the detection of cytokine receptor dimerization.
Andersen SS; Hvid M; Pedersen FS; Deleuran B
Cytokine; 2013 Oct; 64(1):54-7. PubMed ID: 23726671
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
Ke L; Xu M; Jiang X; Sun X
Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
[TBL] [Abstract][Full Text] [Related]
9. EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma.
Toki MI; Carvajal-Hausdorf DE; Altan M; McLaughlin J; Henick B; Schalper KA; Syrigos KN; Rimm DL
J Thorac Oncol; 2016 Nov; 11(11):1901-1911. PubMed ID: 27449805
[TBL] [Abstract][Full Text] [Related]
10. In Situ Proximity Ligation Assay (PLA) Analysis of Protein Complexes Formed Between Golgi-Resident, Glycosylation-Related Transporters and Transferases in Adherent Mammalian Cell Cultures.
Maszczak-Seneczko D; Sosicka P; Olczak T; Olczak M
Methods Mol Biol; 2016; 1496():133-43. PubMed ID: 27632007
[TBL] [Abstract][Full Text] [Related]
11. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
[TBL] [Abstract][Full Text] [Related]
12. ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.
Gainor JF; Varghese AM; Ou SH; Kabraji S; Awad MM; Katayama R; Pawlak A; Mino-Kenudson M; Yeap BY; Riely GJ; Iafrate AJ; Arcila ME; Ladanyi M; Engelman JA; Dias-Santagata D; Shaw AT
Clin Cancer Res; 2013 Aug; 19(15):4273-81. PubMed ID: 23729361
[TBL] [Abstract][Full Text] [Related]
13. Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.
Wang MC; Wang CL; Chen TL; Chang JW; Lu JJ; Chang PY; Chiou CC
Clin Chem Lab Med; 2017 Oct; 55(12):1979-1986. PubMed ID: 28787267
[TBL] [Abstract][Full Text] [Related]
14. ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
Alì G; Proietti A; Pelliccioni S; Niccoli C; Lupi C; Sensi E; Giannini R; Borrelli N; Menghi M; Chella A; Ribechini A; Cappuzzo F; Melfi F; Lucchi M; Mussi A; Fontanini G
Arch Pathol Lab Med; 2014 Nov; 138(11):1449-58. PubMed ID: 24885803
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Matsunaga S; Shuto T
Cureus; 2021 Dec; 13(12):e20398. PubMed ID: 35047245
[TBL] [Abstract][Full Text] [Related]
16. [Mutations of EGFR gene and EML4-ALK fusion gene in superficial lymph node of non-small cell lung cancer].
Wei L; Li X; Yu Z
Zhonghua Yi Xue Za Zhi; 2015 Jul; 95(26):2070-3. PubMed ID: 26710868
[TBL] [Abstract][Full Text] [Related]
17. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.
Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
BMC Med; 2012 Mar; 10():28. PubMed ID: 22436374
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
20. A proximity ligation assay using transiently transfected, epitope-tagged proteins: application for in situ detection of dimerized receptor tyrosine kinases.
Gajadhar A; Guha A
Biotechniques; 2010 Feb; 48(2):145-52. PubMed ID: 20359299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
